Targeting the expression of T antigens with selinexor (KPT‐330) shows promise for Merkel cell polyomavirus‐positive Merkel cell carcinoma treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the expression of T antigens with selinexor (KPT‐330) shows promise for Merkel cell polyomavirus‐positive Merkel cell carcinoma treatment

Published:2021-03 Issue:6 Volume:184 Page:1185-1187
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Gupta R.¹^ORCID,Simonette R.A.²,Doan H.Q.³,Rady P.L.²,Tyring S.K.²

Affiliation:

1. Department of Dermatology Baylor College of Medicine Houston TX USA

2. Department of Dermatology The University of Texas McGovern Medical School Houston TX USA

3. Department of Dermatology Division of Internal Medicine The University of Texas MD Anderson Cancer Center Houston TX USA

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19801

Reference8 articles.

1. Merkel cell carcinoma

2. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics

3. There is still a place for tumour‐targeted therapies in Merkel cell carcinoma in the era of immune checkpoint inhibitors

4. Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens

5. In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of selinexor on prostaglandin synthesis in virus-positive Merkel cell carcinoma cell lines;Archives of Dermatological Research;2024-06-01

2. Selinexor targets expression of metabolic genes in Merkel cell carcinoma cells;2023-10-10

3. Effect of selinexor on lipogenesis in virus-positive Merkel cell carcinoma cell lines;Clinical and Experimental Dermatology;2023-05-16

4. Current treatments and emerging therapies of human polyomavirus‐associated skin diseases: a comprehensive review;International Journal of Dermatology;2022-12-28

5. The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive review;Journal of Cancer Research and Clinical Oncology;2022-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3